Fortitude Family Office’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44
| Closed | -$1.48K | – | 2048 |
|
|
2025
Q1 | $1.48K | Hold |
44
| – | – | ﹤0.01% | 969 |
|
|
2024
Q4 | $2.25K | Hold |
44
| – | – | ﹤0.01% | 1009 |
|
|
2024
Q3 | $2.25K | Hold |
44
| – | – | ﹤0.01% | 980 |
|
|
2024
Q2 | $1.97K | Hold |
44
| – | – | ﹤0.01% | 807 |
|
|
2024
Q1 | $2.06K | Hold |
44
| – | – | ﹤0.01% | 816 |
|
|
2023
Q4 | $1.57K | Buy |
+44
| New | +$1.57K | ﹤0.01% | 902 |
|